Abstract
We performed in vivo hyperspectral imaging in a preclinical cancer model to capture key metabolic endpoints (glucose uptake, mitochondrial membrane potential, and vascular oxygenation) to successfully distinguish metastatic and non-metastatic tumors.
© 2016 Optical Society of America
PDF ArticleMore Like This
Caigang Zhu, Amy F. Martinez, Martin Li, Hannah L. Martin, Brian Crouch, Fangyao Hu, Helen A. Murphy, Marianne Lee, and Nimmi Ramanujam
OmS2D.1 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2017
Caigang Zhu, Hannah L. Martin, Martin Li, Brian Crouch, Amy F. Martinez, Gregory M. Palmer, Mark W. Dewhirst, and Nimmi Ramanujam
CF2B.2 Clinical and Translational Biophotonics (Translational) 2018
Lisa Rebello and Narasimhan Rajaram
MW4A.3 Microscopy Histopathology and Analytics (Microscopy) 2020